STATINS PREVENT CORONARY HEART-DISEASE

被引：23

作者：

OLIVER, MF

机构：

[1] National Heart and Lung Institute, Imperial College, London

来源：

LANCET | 1995年 / 346卷 / 8987期

关键词：

D O I：

10.1016/S0140-6736(95)92399-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1378 / 1379

页数：2

共 16 条

[1] EFFECT OF PARTIAL ILEAL BYPASS-SURGERY ON MORTALITY AND MORBIDITY FROM CORONARY HEART-DISEASE IN PATIENTS WITH HYPERCHOLESTEROLEMIA - REPORT OF THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) [J].

BUCHWALD, H ;

VARCO, RL ;

MATTS, JP ;

LONG, JM ;

FITCH, LL ;

CAMPBELL, GS ;

PEARCE, MB ;

YELLIN, AE ;

EDMISTON, WA ;

SMINK, RD ;

SAWIN, HS ;

CAMPOS, CT ;

HANSEN, BJ ;

TUNA, N ;

KARNEGIS, JN ;

SANMARCO, ME ;

AMPLATZ, K ;

CASTANEDAZUNIGA, WR ;

HUNTER, DW ;

BISSETT, JK ;

WEBER, FJ ;

STEVENSON, JW ;

LEON, AS ;

CHALMERS, TC .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :946-955

[2] REDUCTION IN CARDIOVASCULAR EVENTS DURING PRAVASTATIN THERAPY - POOLED ANALYSIS OF CLINICAL EVENTS OF THE PRAVASTATIN ATHEROSCLEROSIS INTERVENTION PROGRAM [J].

BYINGTON, RP ;

JUKEMA, JW ;

SALONEN, JT ;

PITT, B ;

BRUSCHKE, AV ;

HOEN, H ;

FURBERG, CD ;

MANCINI, J .

CIRCULATION, 1995, 92 (09) :2419-2425

[3]

DAYTON S, 1969, CIRCULATION S2, V39, P63

[4] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[5] EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS [J].

FURBERG, CD ;

ADAMS, HP ;

APPLEGATE, WB ;

BYINGTON, RP ;

ESPELAND, MA ;

HARTWELL, T ;

HUNNINGHAKE, DB ;

LEFKOWITZ, DS ;

PROBSTFIELD, J ;

RILEY, WA ;

YOUNG, B .

CIRCULATION, 1994, 90 (04) :1679-1687

[6] EFFECTS OF LIPID-LOWERING BY PRAVASTATIN ON PROGRESSION AND REGRESSION OF CORONARY-ARTERY DISEASE IN SYMPTOMATIC MEN WITH NORMAL TO MODERATELY ELEVATED SERUM-CHOLESTEROL LEVELS - THE REGRESSION GROWTH EVALUATION STATIN STUDY (REGRESS) [J].

JUKEMA, JW ;

BRUSCHKE, AVG ;

VANBOVEN, AJ ;

REIBER, JHC ;

BAL, ET ;

ZWINDERMAN, AH ;

JANSEN, H ;

BOERMA, GJM ;

VANRAPPARD, FM ;

LIE, KI .

CIRCULATION, 1995, 91 (10) :2528-2540

[7]

LORD I, 1992, J CLIN EPIDEMIOL, V45, P849, DOI 10.1016/0895-4356(92)90068-X

[8]

OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069

[9]

OLIVER MF, 1994, LANCET, V344, P633

[10]

PEDERSEN TR, 1995, LANCET, V345, P1274

← 1 2 →